It emerged this week that the American pharmaceutical company Novavax will be using a plant near Prague for the production of a vaccine against the coronavirus. The vaccine is set to go into trial production in October ahead of full production next year – and should be tried out on Czech volunteers in the final test phase. Czech Radio’s Petr Dudek spoke to Novavax CEO Stanley Erck about the company’s plans.


We're not around right now. But you can send us an email and we'll get back to you, asap.


Log in with your credentials

Forgot your details?